Title: Epinephrine Market to 2027
1Epinephrine Market
Epinephrine Market to 2027 - Global Analysis and
Forecasts By Product Type (Prefilled Syringes,
Auto-Injectors, Ampoules and Vials) Application
(Anaphylaxis, Superficial Bleeding, Respiratory
Disorders, Cardiac Arrest) Distribution Channel
(Retail Pharmacies, Hospital Pharmacies, Online
Pharmacies) and Geography
2Current and future Market Scenario
Epinephrine Market
- According to our new market research study on
Epinephrine Market to 2028 Global Analysis and
Forecast by Type, Treatment, and End User, the
market was valued at US 2,247.87 million in
2018 and it is projected to reach US 4,207.88
million by 2027 it is expected to grow at a CAGR
of 8.3 from 2019 to 2027. - The global epinephrine market, based on the type,
is segmented into auto-injectors, prefilled
syringes and ampoules vials. The auto-injectors
segment led the epinephrine market in 2019, and
it is expected to retain its dominance during the
forecast period. Key factors that are driving
growth of the market are increasing anaphylaxis
cases and introduction of generic version of
epinephrine. However, lack of availability of
epinephrine auto injectors and their low-cost
alternatives is likely to have a negative impact
on the growth of the market in the coming
years.
3Market Segments
Epinephrine Market
By Product Type Prefilled Syringes Auto-Injectors
Ampoules and Vials
By Application Anaphylaxis Superficial
Bleeding Respiratory Disorders Cardiac Arrest
By Distribution Channel Retail
Pharmacies Hospital Pharmacies Online Pharmacies
4Leading Players
Epinephrine Market
Company Profiles in Epinephrine Market
are MYLAN N.V. Abbott ALK ABELLO Amneal
Pharma Kaleo LINCOLN MEDICAL LTD
(BioProject) Teva Pharmaceuticals Ltd Adamis
Pharmaceuticals Corporation (Novartis
AG) Emirade Aurum Pharma
5 Epinephrine Market
Access Full Research Report at
https//www.theinsightpartners.com/reports/epineph
rine-market
Thank You!